DoD Kidney Cancer, Clinical Consortium Award — Defense Health Agency Contracting Activity - DHACA funding opportunity
Defense Health Agency Contracting Activity - DHACA · Federal agency

DoD Kidney Cancer, Clinical Consortium Award

The Clinical Consortium Award mechanism provides support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute phase 2 or phase 2-linked phase 1 (phase 1/2) kidne...

60
match
Deadline 954 days ago Location Alabama Type grant Level Federal Closed posted Jul 13, 2023
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: total funding pool ~$17,280,000.
  • Next deadline: November 9, 2023.
  • Issued by: Defense Health Agency Contracting Activity - DHACA.
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Deadline
954 days ago
Nov 9, 2023
Total pool
$17.3M

About this opportunity

The Clinical Consortium Award mechanism provides support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute phase 2 or phase 2-linked phase 1 (phase 1/2) kidney cancer clinical trials. These trials will include investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of kidney cancer. Applicants are expected to demonstrate a broad understanding of kidney cancer research, including knowledge of the current state of clinical studies and priorities related to kidney cancer, and are encouraged to familiarize themselves with the FY23 KCRP’s Overarching Strategic Goals and Focus Areas and to consider this material when preparing their application. Support from this award is to be directed toward Consortium infrastructure needs rather than direct support of the trials themselves.The principal goal of the KCRP Clinical Consortium Award is to combine the efforts of leading investigators to bring to market strategies and interventions to improve patient outcomes and significantly decrease the impact of the disease. To facilitate global investigations, and international institutions are encouraged to apply. Submissions from institutions with access to patients from high-risk, underserved, and/or military populations (as described in the FY23 KCRP Overarching Strategic Goals and Focus Areas) are especially encouraged.The FY23 Clinical Consortium Award mechanism will be used to select and fund six Clinical Research Sites and one Coordinating Center. PIs will be required to indicate whether the institution is applying as either the Coordinating Center with a Clinical Research Site or as a Clinical Research Site only. Institutions applying as the Coordinating Center, if not selected for funding, have the option to still be considered as a Clinical Research Site only. The Coordinating Center and Clinical Research Sites will be jointly responsible for conducting phase 2 and phase 1/2 clinical trials focused on kidney cancer therapeutic interventions. The Coordinating Center and Clinical Research Sites funded by the FY23 KCRP Clinical Consortium Award will work with additional Clinical Research Sites that may be funded by the KCRP in future fiscal years. Additional details regarding the structure of the Consortium are described below.The Coordinating Center, in addition to functioning as a Clinical Research Site, will serve as the Consortium information and planning nexus providing data management support services to participating Clinical Research Sites to implement Consortium clinical trials in a timely manner. Responsibilities of the Coordinating Center will include coordinating the clinical trial selection process, protocol coordination, regulatory coordination, study management and monitoring, data collection and management, statistical support, and intellectual/material property coordination. The Coordinating Center will also be responsible for launching two clinical trials, with funding already secured, to be initiated by the Consortium within the first 6 months of the performance period. In addition, the Coordinating Center will coordinate and promote best practices for human subject recruitment and will aid Clinical Research Sites in directing potential subjects to the most appropriate trials. All Sites (Clinical Research Sites and the Coordinating Center) will be required to participate in at least one of these two initial clinical trials.Collectively, the Coordinating Center Principal Investigator (PI), the PI from each Clinical Research Site, and consumer advocates will constitute the Clinical Consortium Steering Committee. The consumer advocates must be kidney cancer patients or caregiver for someone with kidney cancer and possess a high-level familiarity with current issues in kidney cancer research. The consumer advocatesf role in the committee should be independent of their employment with a participating institution.

Funding agency

Tags

Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID349278
PostedJul 13, 2023

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.